Avadel Pharmaceuticals PLC
AVDLDelisted Feb 12, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001012477
Avadel Pharmaceuticals PLC was delisted on Feb 12, 2026; its insiders filed their last Form 4 on Feb 18, 2026; 208 institutions reported holding it in 13F filings for Q4 2025, worth $1.60B in total; no superinvestor held it.
Q3 2025 vs. Q2 2025
How the institutions holding Avadel Pharmaceuticals PLC changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 174 | 4 | 188 | +18 |
| Shares | 81.6M | 152.3K | 80.0M | −1.46M (−1.8%) |
| Value | $721.2M | $1.35M | $1.22B | +$501.4M (+69.6%) |
4 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (36)
Institutions that held Avadel Pharmaceuticals PLC at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (18)
Institutions that held Avadel Pharmaceuticals PLC at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Invenomic Capital Management LP | 802,994 | $7.11M |
| Cubist Systematic Strategies, LLC | 273,736 | $2.42M |
| Point72 Asset Management, L.P. | 202,815 | $1.79M |
| UBS Asset Management Americas Inc | 77,955 | $689.9K |
| Quarry LP | 38,300 | $339.0K |
| Mach-1 Financial Group, Inc. | 37,067 | $328.0K |
| Jain Global LLC | 26,314 | $232.9K |
| Fox Run Management, L.L.C. | 21,436 | $189.7K |
| Virginia Retirement Systems Et Al | 19,900 | $176.1K |
| Dynamic Technology Lab Private Ltd | 17,439 | $154.0K |
| Atria Investments LLC | 16,841 | $149.0K |
| Occudo Quantitative Strategies LP | 14,046 | $124.3K |
| Verition Fund Management LLC | 13,010 | $115.1K |
| Sanctuary Advisors, LLC | 11,873 | $105.1K |
| Raymond James Financial Inc | 7,393 | $65.4K |
| Caitong International Asset Management Co., Ltd | 543 | $4.81K |
| Skopos Labs, Inc. | 105 | $930 |
| Fortitude Family Office, LLC | 55 | $487 |
Not filed for Q3 2025 yet (4)
Institutions that held Avadel Pharmaceuticals PLC at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Avantax Advisory Services, Inc. | 96,901 | $857.6K |
| HAP Trading, LLC | 42,832 | $379.1K |
| CIBC World Markets Corp | 11,008 | $97.4K |
| First Horizon Advisors, Inc. | 1,542 | $13.6K |